- Patent Title: β-substituted β-amino acids and analogs as chemotherapeutic agents
-
Application No.: US15826042Application Date: 2017-11-29
-
Publication No.: US10245246B2Publication Date: 2019-04-02
- Inventor: Bernd Jandeleit , Wolf-Nicolas Fischer , Kerry J. Koller
- Applicant: QUADRIGA BIOSCIENCES, INC.
- Applicant Address: US CA Los Altos
- Assignee: QUADRIGA BIOSCIENCES, INC.
- Current Assignee: QUADRIGA BIOSCIENCES, INC.
- Current Assignee Address: US CA Los Altos
- Main IPC: A61K31/197
- IPC: A61K31/197 ; C07C229/08 ; C07C233/35 ; C07C271/46 ; C07C309/69 ; C07F9/48 ; A61K31/662 ; C07C229/22 ; C07C229/34 ; C07C237/30 ; C07C239/20 ; C07F9/32 ; C07C237/04 ; C07C229/42 ; C07C237/20 ; C07C309/66 ; C07F9/30 ; A61K31/255 ; A61K31/27

Abstract:
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.
Public/Granted literature
- US20180078517A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS Public/Granted day:2018-03-22
Information query
IPC分类: